Clinical Trial Update: A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating an Angiotensin-II receptor blocker for cardiovascular remodeling is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coarctation of the Aorta
• Hypertension

Drugs mentioned

• Angiotensin-II Receptor Blocker (angiotensin II receptor blocker)

Snippet

Sponsor: Mayo Clinic | Conditions: Coarctation of Aorta, High Blood Pressure | Phase 3 | Status: RECRUITING